In melanoma cells, PD-L2 is responsive to IFN-beta (β) and IFN-γ and is regulated through the transcription factors IRF1 and STAT3 that bind to the PD-L2 promoter.21 This evidence concerns the gene PDCD1LG2 and melanoma.